Breaking News on Global Pharmaceutical Technology & Manufacturing

Headlines > All Ingredients News

European API makers must invest to compete with India, says Infa Group

14-Oct-2015 - Clients are turning their backs on low-cost economies like India and returning to Infa Group, the Italian API maker says.

It's not easy being green, but biotechs should consider it according to Piramal

13-Oct-2015 - Pharma and biotech firms not using ‘green chemistry’ to make their products incur higher costs and risk losing market share according to Piramal.

BASF new efficiency drive may involve job cuts

05-Oct-2015 - BASF expects to reduce its workforce though natural employee turnover rather than redundancies as part of a new €1bn cost cutting plan.

Pfizer hiring 40 at its Lipitor and Viagra API plants in Ireland

02-Oct-2015 - Over 40 new jobs will be created at Pfizer’s manufacturing sites in Cork, Ireland, including at a bulk Lipitor facility once earmarked for closure.

Johnson Matthey to take on all Pharmorphix staff

Johnson Matthey buys Sigma-Aldrich solid state chem unit to boost API business

01-Oct-2015 - Johnson Matthey has bought Sigma-Aldrich’s Pharmorphix division to add a 'significant' customer base and expand its European API business.

Pharmas factor green considerations into sourcing decisions say experts

30-Sep-2015 - Drug companies still outsource to cut costs but environmental concerns and therefore contractors’ green credentials are increasingly important say industry experts. 

Evonik hikes up pharma excipient prices

28-Sep-2015 - Increasing QbD needs and a range of technical service centres have driven up the prices of Evonik’s drug delivery excipient portfolio, the company says.

Better health monitoring can cut adverse drug reactions, say researchers

24-Sep-2015 - Better health monitoring could cut the number of adverse drug reactions and guide development of safer formulations say researchers.

Ashland to spin specialty chemicals business into standalone company

24-Sep-2015 - It will be business as usual for pharma customers as Ashland approves a plan to separate into two independent companies, the ingredients firm says.

India mulls reclassifying vitamins as drugs if they come with health claims

23-Sep-2015 - India may classify vitamin supplements as drugs rather than foods if the manufacturers of such products claim they can treat or prevent disease.

Innovate UK grants $2.9m to cancer enzyme inhibitor hunt

22-Sep-2015 - The UK government is granting £1.9m ($2.9m) to pharma company Mission Therapeutics to create small-molecule cancer inhibitors.

SA police shut down three counterfeit drug making faciltiies in INTERPOL swoop

21-Sep-2015 - South African Police shut down three counterfeit drug making plants last weekend in an INTERPOL-co-ordinated operation that seized 150 tonnes of fake medicines.


Indian firm reconstructing API plant after being slapped with USFDA warning

16-Sep-2015 - Indian API maker Pan Drugs is reconstructing its manufacturing suite after holes in the wall and rusty equipment landed the facility a US FDA warning.

Tree resin blocks K-channels to treat neurology conditions

10-Sep-2015 - Resin from conifer trees hold the key to future epilepsy APIs, according to Swedish scientists.

Low level mercury in drugs safe but EU needs to set limits say Polish researchers

07-Sep-2015 - The EU needs to better define mercury limits for drugs and dietary supplements say Polish researchers who want pharmaceuticals in Europe to be tested more regularly.

AMRI boosts opiate API biz through tech transfer and supply deal with Saneca

01-Sep-2015 - AMRI has inked a deal with Slovakia’s Saneca Pharmaceuticals to bolster its opium-derived API portfolio.

Fareva buys Merck & Co API plant in France and outlines plan to invest €25m

01-Sep-2015 - Fareva has bought an API plant in France from Merck & Co. and outlined plans to turn it into a high-potency actives site.

Cure not kill: Dynamite ingredient can improve cancer treatment says study

27-Aug-2015 - Nitroglycerin could make cancer drugs more effective say researchers trying to use the dynamite ingredient to help destroy tumours.

To supply the Dane: Novo expects First API batch in 2020

27-Aug-2015 - Novo Nordisk has confirmed it will build an API plant in the US, telling this publication a desire to have manufacturing capacity in the key market for its oral diabetes candidate, semaglutide, drove the decision.

DSM says plans to cut 1,100 jobs prompted by recent pharma moves not shareholder pressure

25-Aug-2015 - Royal DSM will make up to 1100 staff redundant by the end of 2017 to cut costs following the formation of its Sinochem JV and pharma products deal with Patheon.

News in brief

AmbioPharma expands US manufacturing site and starts work on global HQ

24-Aug-2015 - Peptide maker AmbioPharma will invest $18.8m to expand its manufacturing operations in South Carolina in a move that it claims will create 100 jobs.

Xellia moves US HQ to North Carolina

20-Aug-2015 - Anti-infectives firm Xellia has moved its North American HQ to the lyophilisation plant in Raleigh, North Carolina that it bought from Fresenius Kabi last July .

Excipient manufacturers raise concerns over stability testing

13-Aug-2015 - Manufacturers of excipients are being sent inappropriate requests for stability data by some regulators and pharma companies, threatening to disrupt the supply chain, IPEC claims.

Laser synthesis technique could provide better APIs

12-Aug-2015 - Scientists in Japan have developed a technique for making crystal forms of active pharmaceutical ingredients (APIs) that until now have been hard to synthesise.

Key Industry Events


Access all events listing

Our events, Shows & Conferences...